Megan Boston Benitec Biopharma Inc. (BNTC) insider trading activity

BNTC Quotes by TradingView

Megan Boston is Executive Director of Benitec Biopharma Inc.. Currently has a direct ownership of 25,907 shares of BNTC, which is worth approximately $261,660. The most recent transaction as insider was on Aug 11, 2023, when has been sold 25,907 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.9K
0% 3M change
0% 12M change
Total Value Held $261,660

Megan Boston Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2023
BUY
Open market or private purchase
-
25,907 Added 50.0%
25,907 Common Stock
MB

Megan Boston

Executive Director
Hayward, CA

Track Institutional and Insider Activities on BNTC

Follow Benitec Biopharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BNTC shares.

Notify only if

Insider Trading

Get notified when an Benitec Biopharma Inc. insider buys or sells BNTC shares.

Notify only if

News

Receive news related to Benitec Biopharma Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BNTC